5,641
Views
4
CrossRef citations to date
0
Altmetric
Articles

An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan

, , , , &
Pages 229-239 | Received 27 Feb 2020, Accepted 15 Mar 2020, Published online: 17 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.